Abstract:Eukaryotic translation initiation factor 3 subunit A (eIF3a) is the largest subunit of the eukaryotic translation initiation factor 3 (eIF3). eIF3a plays an integral role in protein biosynthesis, hence impacting the onset, development, and treatment of tumors. The proteins regulated by eIF3a are still being explored in vivo . In this study, a Cre-loxP system was used to generate eIF3a conditional knockout mice. Tandem mass tag (TMT) labeling with LC-MS/MS analysis was used to identify differentially expressed proteins (DEPs) in fat, lungs, skin, and spleen tissue of the eIF3a knockout mice and controls. Bioinformatics analysis was then used to explore the functions and molecular signaling pathways of these protein landscapes. It was observed that eIF3a is essential for life sustenance. Abnormal tissue pathology was found in the lungs, fat, skin, spleen, and thymus. In total, 588, 210, 324, and 944 DEPs were quantified in the lungs, fat, skin, and spleen, respectively, of the eIF3a knockout mice as compared to the control. The quantified differentially expressed proteins were tissue-specific, except for eight proteins shared by the four tissues. A broad range of functions for eIF3a, including cellular signaling pathway, immune response, metabolism, defense response, phagocytes, and DNA replication, has been revealed using bioinformatics analysis. Herein, several pathways related to oxidative stress in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, including nitrogen metabolism, peroxisome, cytochrome P450 drug metabolism, pyruvate metabolism, PPAR signaling pathway, phospholipase D signaling pathway, B-cell receptor signaling pathway, ferroptosis, and focal adhesion, have been identified. Collectively, this study shows that eIF3a is an essential gene for sustaining life, and its downstream proteins are involved in diverse novel functions beyond mRNA translational regulation.

Recent research progress of eIF3 in biological function

Research progress on eIF3 a and cancer

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Eukaryotic Translation Initiation Factor 3 and Tumor

eIF3a: A new anticancer drug target in the eIF family.

eIF3d: A driver of noncanonical cap–dependent translation of specific mRNAs and a trigger of biological/pathological processes

The Biological Roles Of Translation Initiation Factor 3b

Eif3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

Eukaryotic Translation Initiation Factors and Tumor

Relationship Between Elf3 Subfamily and the Development of Tumor

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

Aberrations in Translation Initiation and Associated Diseases: From theeIF3a Perspective

Aberration in Translation Initiation and Associated Diseases: Role of the Eukaryotic Translation Initiation Factor 3A.

Research Progress and Prospect of Eukaryotic Initiation Factor 4A (eIF4A)

Role of Eif3a in Regulating Cell Cycle Progression

Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation.

eIF3 S10 and tumor

Overexpression of Eif3e is Correlated with Colon Tumor Development and Poor Prognosis.

Translational Regulator Eif2α in Tumor

eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation.

Proteomic profiling of eIF3a conditional knockout mice